How real-world data is powering rare disease research Part 1. RWD advances in North America

Published on: Apr 18, 2025

As real-world data (RWD) transforms the drug development landscape, its power to advance research is becoming tangible in the most challenging therapeutic arena—rare diseases. In this series, Parexel experts discuss current initiatives in North America, Europe and China that are accelerating the use of RWD in rare disease research.

Download the whitepaper for North America

Return to Insights Center

Related Insights

Related Insights

Whitepaper

How real-world data is powering rare disease research Part 2. RWD advances in Europe

Apr 18, 2025

Whitepaper

How real-world data is powering rare disease research Part 3. RWD advances in China

Apr 18, 2025

Blog

Studying rare cancer patient populations using integrated genomic and real-world data

Aug 30, 2023

Blog

Advancing rare disease research: Exploring opportunities for Bayesian methods with FDA’s upcoming guidance

Jun 17, 2025

Playbook

Insights from the 2022 R&D Innovation Survey

Feb 17, 2023

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Show more